including the rat, inducing tumors in the liver as well as many The ability of human liver cytochrome P450s to metabolize other organs, and is therefore a suspected human carcinogen the environmental carcinogen N-nitrosodi-n-propylamine (2, 3) . Dialkylnitrosamines must first be activated in vivo and (NDPA) was investigated. The maximum rate of NDPA the most critical step in activation is the cytochrome P450 depropylation in seven human liver microsomal samples (P450)-mediated α-hydroxylation (4,5; Figure 1 ). This is was 1.15 nmol/min/mg (range 0.53-2.60). Troleandomycin, believed to occur through the initial formation of a α-nitrosama P450 3A4/5 inhibitor, inhibited depropylation modestly ino radical which recombines with the hydroxyl radical at the (10-60%) in three of seven samples. Diethyldithiocarbamic P450 active site (5, 6) . For NDPA the α-hydroxy compound acid, a potent 2E1 inhibitor, and a 2E1 inhibitory monowould spontaneously decompose to form propionaldehyde clonal antibody (mAb) inhibited the reaction in all samples and propyldiazohydroxide. The propyldiazohydroxide readily (23 to almost 100%). No significant inhibition was observed decomposes to the propyldiazonium ion, a highly electrophilic with the 2C9 inhibitor sulfaphenazole or with mAbs to species that propylates DNA inducing various types of damage 3A4, 2A6 and 2D6. The 2C8/9/18/19 mAb inhibited depro- (7) (8) (9) . P450s can also catalyze the denitrosation of dialkylnitropylation in one sample by~25% and~25% of the activity samines, which is generally believed to be a detoxification in another sample could not be accounted for by the pathway (10) . With nitrosodimethylamine (NDMA), studies inhibitors. Denitrosation of NDPA by three of the microstrongly suggest that denitrosation is predominantly an oxidatsomal samples exhibited low K m values (51-86 µM) while ive pathway in which the putative α-nitrosamino radical two of these also had high K m values (2.6 and 4.6 mM).
fragments to nitric oxide and an imine (6,11; shown in Figure 1 Purified human P450 2B6 and 3A4 and human P450 2A6, for NDPA). Nitric oxide and the imine are non-enzymatically 2C8, 2C9 and 2D6 membranes had high K m values relative oxidized and hydrolyzed, respectively, to nitrite, an amine and to their maximum turnover rates and are unlikely to an aldehyde. There is also evidence for a P450-mediated one participate in NDPA metabolism at micromolar concentraelectron reduction of various aromatic nitrosamines, resulting tions. Conversely, purified rabbit 2E1 exhibited K m and in the formation of nitric oxide and a secondary amine (12, 13) . V max values for depropylation of 52 µM and 13.4 nmol Due to the similarity in structure with NDMA it is speculated propionaldehyde/min/nmol P450, respectively. Values for that denitrosation of NDPA is an oxidative process, although denitrosation were 66 µM and 1.44 nmol nitrite/min/nmol there is no direct evidence for this. Since microsomal denitro-P450, respectively. The toxicity of NDPA in transfected sation of dialkylnitrosamines appears to occur at a rate that is human liver epithelial cells expressing 2E1 was dose~1 0-30% of dealkylation (6, 14, 15) , aldehyde formation is dependent down to 50 µM. No toxicity was observed in commonly measured to estimate the rate of activation, e.g. control cells or those expressing 2A6. These results indicate α-hydroxylation. that 2E1 is the major human liver microsomal isoform It was previously shown in our laboratory that P450 2E1 responsible for NDPA metabolism at low micromolar concentrations. We also show that purified P450s catalyze and 2B1 are the isozymes responsible for depropylation of the denitrosation of NDPA at~10-20% of the rate of NDPA by rat liver microsomes (16). Concordantly, these depropylation and K m values for both reactions are the isozymes were shown to metabolize NDPA to toxic and DNAsame for each isozyme. This is consistent with the formation damaging species at low micromolar concentrations in primary of an initial intermediate common to both pathways, rat hepatocyte cultures (17,18). Since 2E1 is highly conserved presumably an α-nitrosamino radical.
across species and exhibits a high degree of substrate specificity, it was thought that it might contribute to NDPA metabolism in humans. Correlations between NDPA depropylation and the Introduction specific activities of 2E1 and 3A have been reported in human liver microsomal samples (19), although the substrate Nitrosamines are a large class of compounds that may be a concentration used was 4 mM, well above the expected factor in the induction of some human cancers due to their physiological concentrations.
To better understand the risk that this carcinogen may pose identify the P450s contributing to the metabolism of NDPA, its spectrophotometrically detectable 2,4-dinitrophenylhydrazone derivative. NDPA was dissolved in acetonitrile; this solvent was Ͻ0.5% in all reactions. Reactions were performed in Tris buffer, pH 7.4, containing 150 mM KCl, 10 mM MgCl 2 (buffer A), 0.5 mg microsomal protein, NDPA, 3 mM semicarbazide (adjusted to pH 7.4) to trap propionaldehyde as its semicarbazone derivative, and an NADPH generating system consisting of 15 mM glucose 6-phosphate, 0.6 mM NADP ϩ and 1 U/ml glucose 6-phosphate dehydrogenase, in a final volume of 1 ml. Incubations containing the P450 mechanism-based inhibitor diethyldithiocarbamic acid (DDC) or the quasiirreversible inhibitor troleandomycin (TAO), both at final concentrations of 20 µM, were pre-incubated for 15 min at 37°C in the presence of the NADPH generating system. The reactions were initiated by adding semicarbazide and NDPA, to final concentrations of 3 and 4 mM, respectively, and incubated for 30 min at 37°C in sealed amber vials. Reactions containing the competitive inhibitor sulfaphenazole (10 µM) were pre-incubated for 3 min with 0.15 mM NDPA and were initiated by adding the NADPH generating system. The incubations were quenched by adding 0.1 ml of a 2:5 mixture of 0.1 M semicarbazide and 50% zinc sulfate containing butyraldehyde as an internal standard. The vials were mixed and placed on ice for 20 min. After addition of 0.1 ml of a saturated solution of barium hydroxide the vials were centrifuged to precipitate the pellet. The supernatant (0.8 ml) was mixed in a two phase medium containing 1.1 ml of a saturated 2,4-dinitrophenylhydrazine (DNPH) solution in 1 N HCl and 1.5 ml hexane. After 35 min, 1 ml of the hexane layer was removed and mixed with 0.35 ml of acetonitrile by vortexing. The acetonitrile layer was removed and an aliquot (0.05 ml) was analyzed using a Waters HPLC equipped with a Rainin microsorb C18 reverse phase column (4.6ϫ250 mm) fitted with an Upchurch in-line filter. The DNPH derivatives Fig. 1 . Proposed mechanism for cytochrome P450-mediated metabolism of were separated isocratically using 55/45% acetonitrile/water and detected at NDPA. The putative α-nitrosamino radical intermediate undergoes oxygen 340 nm using a Gilson HM Holochrome detector. Control reactions omitted rebound at the enzymes active site to form the α-hydroxynitrosamine (a) or the inhibitor. Background levels of propionaldehyde were determined by fragments to nitric oxide and the imine (b).
running control reactions without the NADPH generating system. Since TAO and sulfaphenazole were dissolved in methanol, an equal volume of methanol was added to their respective control reactions. Escherichia coli membrane preparations containing human P450s. Additionally, toxicity studies were performed in cell
Denitrosation assays using human liver microsomes lines derived from human liver epithelial cells which had been
Denitrosation of NDPA results in the formation of nitrite, which was determined using a colorimetric assay (10) . Incubations contained buffer A, the NADPH transfected so that they expressed individual human P450s.
generating system, 0.5-1.5 mg microsomal protein and NDPA in a final volume of 1 ml. All incubations contained the same concentration of
Materials and methods
acetonitrile, which was never greater than 0.5%. After a 2 min pre-incubation at 37°C, the reactions were initiated by adding the NADPH generating system Chemicals and quenched 30 min later by adding a 50% zinc sulfate solution (25 µl). A NDPA, NDMA, semicarbazide HCl, N-(1-naphthyl)ethylenediamine dihydro-50 µl aliquot of a saturated barium hydroxide solution was added and the chloride, sulfanilamide, sulfaphenazole, troleandomycin, diethyldithiocarbamic reactions centrifuged. To 0.9 ml of the supernatant was added 0.25 ml of acid, NADP ϩ , NADPH, glucose 6-phosphate, glucose 6-phosphate dehydrosulfanilamide (0.1 M in 3 N HCl), followed by addition of 0.125 ml of genase (Type IX), bovine serum albumin, dilauroyl-L-α-phosphatidylcholine,
were mixed and incubated in the dark for 30 min to allow the azo dye to serine, catalase and glutathione were obtained from Sigma Chemical Co.
develop, then measured spectrophotometrically at 540 nm using a SLM (St Louis, MO). Butyraldehyde (99% pure) and propionaldehyde (97% Aminco 3000 spectrophotometer. Background nitrite was determined by pure) were obtained from Aldrich Chemical Co. (Milwaukee, WI). 2,4-adding the microsomal protein to the reactions after they had been quenched. Dinitrophenylhydrazine and zinc sulfate were obtained from J.T. Baker
Standards containing known quantities of sodium nitrite instead of NDPA Chemical Co. (Phillipsburg, NJ). HPLC grade acetonitrile and hexanes were were run in the same manner as the samples and reactions were run in duplicate. from Fisher (Pittsburgh, PA). Tissue culture media and materials were obtained Metabolism assays using purified P450s from Biofluids Inc. (Rockville, MD), except for epidermal growth factor, human plasma fibronectin, fetal bovine serum, L-glutamine, gentamycin and Human P450 3A4 and 2B6, rabbit P450 2E1 and rat NADPH-cytochrome Hank's balanced salt solution, which were obtained from Gibco BRL (Grand P450 reductase (reductase) were expressed in E.coli and purified (25) (26) (27) . Rat Island, NY). P450 2B1 and cytochrome b 5 were purified from rat liver microsomes (25, 27) . Purified 2E1, 2B6 and 2B1 were reconstituted with reductase in dilauroyl-LPreparation of human liver microsomes phosphatidylcholine (DLPC) for 1 h on ice (26,27). Cytochrome b 5 was added Sections of frozen human liver samples were a gift from Dr F.P.Guengerich to reconstitution mixtures containing 2E1 and 2B6. Incubations contained (Vanderbilt University, Nashville, TN). Microsomes were prepared as previ-P450 (0.025-0.1 nmol), cytochrome b 5 (in 2E1 and 2B6 reactions) and ously described (21) with minor modifications indicated here. The liver tissue reductase in the ratio 1:1:2, 400 µg DLPC/nmol P450, 125 U/ml catalase, was placed in buffer (100 mM potassium phosphate, pH 7.4, 1 mM EDTA NDPA, 0.2% acetonitrile, 50 mM potassium phosphate buffer, pH 7.4, and 150 mM KCl) on ice, minced and homogenized with a Polytron containing 40 µg/ml bovine serum albumin (buffer B) or, for 2E1 denitrosation, homogenizer using 10 s bursts at~7000 r.p.m. Butylated hydroxytoluene was buffer A in a final volume of 1 ml. Reactions were pre-incubated for 3 min omitted from the wash buffer and microsomal pellets were resuspended in a at 37°C, initiated by adding 1 mM NADPH and run for 10 (2E1 and 2B1) or buffer containing 100 mM potassium phosphate, pH 7.4, 1 mM EDTA and 30 (2B6) min. For a typical reconstitution of 3A4 the following components 0.25 M sucrose and stored at -80°C. Protein content was determined were added in the order indicated so that the final contents were: 50 µg of a using the bicinchonic acid method (22) and P450 content was determined 1:1:1 mixture of L-α-dilauroyl-and L-α-dioleyl-sn-glycero-3-phosphocholines spectrally (23).
and phosphatidyl serine, 500 µg cholic acid, 0. (24), in which the propionaldehyde product is converted to were added so that the final volume was 1 ml. Incubations contained an aliquot (0.08 ml) of the reconstitution mixture, 2.5% acetonitrile and NDPA in reaction buffer so that the final volume was 1 ml. To allow for dissolution of the higher concentrations of NDPA, 3A4 reactions were pre-incubated for 10 min at 37°C. Reactions were initiated by adding 1 mM NADPH and incubated for 15 min. Reactions were quenched and analyzed for product formation as described above for the microsomal assays. Standards for nitrite contained all of the reaction components used in the purified P450 assays. Control reactions omitted NADPH. 2E1, 3A4, 2B6 and 2B1 did not metabolize propionaldehyde at the substrate concentrations used in the assays. Reactions were run in duplicate.
NDPA depropylation by solubilized membranes containing human P450s
Co-expression of P450s 2A6, 2C8, 2C9 and 2D6 with reductase and solubilization of the E.coli membranes were performed as previously described (25) . Reaction mixtures contained solubilized membranes (0.02-0.1 nmol P450), the NADPH generating system, 50 µg catalase, NDPA, 0.4% acetonitrile and buffer B in 1 ml. After a 2 min pre-incubation at 37°C, the reactions were initiated by adding the NADPH generating system, quenched 30 min later and analyzed for propionaldehyde formation as described above. Since 2C9 membranes were found to metabolize propionaldehyde to some extent (25% Fig. 2 . Inhibition of human liver microsomal NDPA depropylation by the in 30 min at 10 µM propionaldehyde), these reactions were also performed P450 isozyme-specific chemical inhibitors DDC (2E1, 2A6 and 2C19) and in the presence of 1 mM semicarbazide, which increased the product yield TAO (3A Based on a previous study with various long chain nitrosamines, P450-mediated metabolism, it was removed from the mAb preparations by it was estimated that a substrate concentration of 4 mM would an overnight dialysis in a borate-buffered solution (200 mM sodium borate, be near saturating in human liver microsomes (14) . Therefore, substrate concentrations (4 mM) (19). In these assays we used cultured in fibronectin/collagen-coated flasks in serum-free liver cell medium this concentration of NDPA to see if our results would agree (29) and maintained in a humidified incubator at 37°C with a 3.6% CO 2 atmosphere.
with those of Bellec and to initially identify contributing P450s
Cytotoxicity assays that could be studied further. Figure 2 shows the extent of inhibition of depropylation by 20 µM DDC and TAO. Since Toxicity was determined by the crystal violet viability assay (30) . Cells were seeded at 75 000 cells/plate on individual fibronectin/collagen-coated both of these are irreversible or quasi-irreversible inhibitors 35ϫ10 mm plates. On the following day the medium was replaced with and they were pre-incubated with the microsomes prior to medium containing the nitrosamine and 0.5% acetonitrile and incubated for substrate addition, the extent of inhibition should not be at 0.2 mM NDPA (Table II) and no inhibition was seen in the microsomes with sulfaphenazole, a potent inhibitor of 2C9, the isozyme(s) inhibited by the mAb in this sample is probably are membrane proteins and when expressed in E.coli they are inserted into the bacterial outer membrane and retain their catalytic activities. Many studies have shown that catalytic is highly specific for the 3A isozymes at a concentration of 20 µM (32) and inhibited depropylation in sample 110 by activities determined using these preparations can be comparable with values determined using purified-reconstituted Ͼ50%, while inhibition in the rest of the samples ranged from 0 to 20%. No significant inhibition was apparent when 10 µM systems or human liver microsomes (36-39). Therefore, the membranes were used to provide an estimate of the ability of sulfaphenazole, a potent 2C9 competitive inhibitor, was used with 0.15 mM NDPA (data not shown). Three of the liver various P450s to depropylate NDPA. All four P450s tested could catalyze the depropylation reaction at the estimated samples in our study had previously been characterized for specific P450 activities and the results are shown in Table I saturating NDPA concentration of 4 mM (Table II) . When the concentration was lowered to 0.2 mM, depropylation by 2A6 (34,35). Our inhibition results are consistent with their findings, e.g. the extent of inhibition by an isozyme-specific inhibitor was 0.8 nmol propionaldehyde/min/nmol P450, still greater than half the maximum rate of 0.65. This indicates that the corresponded to the level of activity of the isozyme in the sample.
K m for 2A6 is below 0.2 mM. Of the other three isozymes only 2D6 could significantly catalyze the reaction at 0.2 mM Inhibition of human liver microsomal depropylation of NDPA NDPA. The rate of the reaction, 0.24 nmol propionaldehyde/ by inhibitory mAbs min/nmol P450, suggests that this concentration is below the The ability of isozyme-specific inhibitory mAbs to inhibit K m value for 2D6. NDPA depropylation in four of the microsomal samples was NDPA metabolism by purified P450s also determined. In these studies we used NDPA at 0.25 mM so that the contribution by isozymes with low affinities would K m and V max were determined for NDPA metabolism using purified P450 isozymes in the reconstituted system and the be minimized. Concentrations lower than 0.25 mM were not used because of concerns regarding product yields that would intrinsic clearance (I Cl ), the ratio V max /K m , was calculated. An isozyme(s) with a higher I Cl will be most effective at catalyzing be below the detection limits. As seen in Figure 3 , inhibition by the 2E1 mAb was Ͼ50% in all four samples and very the reaction at low sub-saturating substrate concentrations, although microsomal levels of the isozymes must also be similar to the inhibition profile seen with DDC, suggesting that 2E1 is the predominant isozyme responsible for deproconsidered when establishing the contribution of a particular P450. The P450s could catalyze both denitrosation and depropylation at this sub-saturating substrate concentration. Little to no inhibition by the 2A6, 3A4 and 2D6 mAbs suggests pylation of NDPA, with the former being~10-20% of the latter (Table III) . Also, K m values for each P450 were the that these isozymes are not significantly involved in NDPA depropylation at the substrate concentration tested. The 2C same, within experimental error, for both reactions. Maximum metabolic rates for denitrosation and depropylation by 3A4 mAb, which is specific for 2C8/9/18/19, did show significant in a relatively low I Cl . Rat 2B1 has previously been shown to contribute significantly to the metabolism and activation of values for depropylation and denitrosation were 52 and 66 µM, respectively. 2E1 also exhibited appreciable V max values of 1.4 86 and 51 µM, similar to the values for denitrosation and and 13.4 nmol/min/nmol for denitrosation and depropylation, depropylation by purified 2E1, and values for the low affinity respectively. The I Cl values of 2E1 and 2B1 were reasonably component were 2.6 and 4.6 mM for samples 110 and P4, comparable and at least 25 times greater than that of 3A4.
respectively (Table IV ). Figure 4 also shows the monophasic P450 2B6, the closest human ortholog to 2B1, was much less denitrosation kinetics exhibited by sample 132, in which efficient at catalyzing depropylation than 2B1 or 2E1 and depropylation was almost completely inhibited by DDC and exhibited an I Cl value for depropylation of 3.0, almost 100 the 2E1-specific mAb. The K m value for this sample was times lower than that of 2B1. Denitrosation assays were not 59 µM, similar to the low K m values in the other two samples performed with 2B6 due to its low activity and the expectation and those of purified 2E1. that the product yields would be below the detection limit.
Cytotoxicity of NDPA in THLE cells expressing P450s Denitrosation of NDPA by human liver microsomes
The ability of human P450s to catalyze the metabolic activation In order to characterize in more detail the ability of the human of NDPA to highly reactive toxic forms was examined in microsomes to metabolize NDPA, we determined the kinetic human cells expressing P450s. These THLE cell lines exhibit constants for NDPA denitrosation by three of the samples.
high levels of the specific transfected human P450 and have Although the constants for depropylation are generally considbeen shown to retain many of the phase II enzymes (29, 43) . ered to be more relevant to activation, these constants could Viability of the cells was determined using the crystal violet not be accurately determined in human microsomes due to staining method, which is a general measure of cytotoxicity. degradation of the propionaldehyde product by the microsomes, Figure 5 shows the viability of THLE cells expressing human as mentioned above. Additionally, semicarbazide could not be 2E1 exposed to 0-2 mM NDPA or NDMA, a potent liver added to trap the aldehyde product and prevent its further toxicant and carcinogen activated by 2E1 to an alkylating metabolism since it is a potent competitive inhibitor of 2E1 species (44) . Both compounds showed a dose-dependent cyto-(42), which has been identified as one of the major contributors toxicity for the 2E1-expressing cells, with toxicity leveling off to NDPA metabolism here and in previous studies (16). Since at~60 and 20% relative survival for NDPA and NDMA, denitrosation by P450s appears to be a constant proportion of respectively. The lowest concentration tested, 50 µM, still depropylation (Table III) , microsomal rates of this reaction showed a statistically significant decrease in viability with can be used as an estimate of activation. All three samples both compounds. No toxicity was observed in control THLE could readily catalyze NDPA denitrosation (Table IV) .
cells not transfected with P450s or THLE 2A6 cells with Samples 110 and P4, which showed significant inhibition of nitrosamine concentrations up to 4 mM (data not shown). depropylation by both DDC and TAO, exhibited biphasic denitrosation kinetics (shown in Figure 4 for sample 110). Discussion This indicates that there are at least two isozymes responsible for NDPA denitrosation in these samples. The K m values for NDPA is a potent rat carcinogen and P450s 2E1 and 2B1 have been shown to be the major isozymes responsible for its the high affinity component catalyzing the denitrosation were P450s mentioned above as contributors to NDPA metabolism at micromolar concentrations. To understand the risk NDPA poses as a human carcinogen, determination of the metabolism of NDPA at physiological concentrations is critical. These concentrations are difficult to establish due to the vast array of possible sources of this compound. NDPA can potentially form when secondary or tertiary amine-based compounds come into contact with nitrosating agents (e.g. oxides of nitrogen) and this has been implicated as the source of low parts per billion levels of NDPA in some foodstuffs and industrial settings (45) (46) (47) (48) . A recent survey of the gastric juice of 71 patients found NDPA levels of 0.10 Ϯ 0.57 nmol/l (49), indicating that exposure of the general population may be low, yet potentially widespread. Other individuals may be at risk for higher exposures. One study detected NDPA in the indicate that their K m values are high relative to their turnover numbers, indicating that they are unlikely to catalyze depropylation at physiological concentrations. It can be inferred activation in the liver of this species (16-18). Our study uses several complementary in vitro approaches to implicate P450 from its I Cl that 2E1-mediated depropylation will occur at high nanomolar concentrations, although activity may be 2E1 as the predominant human liver microsomal isozyme catalyzing depropylation, which reflects the rate of insignificant at lower concentrations. 2E1 is constitutively expressed and highly inducible by alcohol (50), suggesting α-hydroxylation, and denitrosation of NDPA at low micromolar concentrations. Purified rabbit 2E1, which has a similar subthat activation of NDPA may be a concern if exposure is high enough. Further investigation of metabolism at lower strate specificity to human and rat 2E1, had K m values of 53 and 66 µM for depropylation and denitrosation, respectively, concentrations with tritium-labeled compounds, as has been done with methyl-n-amylnitrosamine and tobacco-specific and significant V max values, resulting in relatively high I Cl values. At 4 mM NDPA our human microsomal samples nitrosamines (51,52), will provide a better understanding of the carcinogenic risk of NDPA. effectively catalyzed depropylation and exhibited significant inhibition by the potent 2E1 chemical inhibitor DDC. Four Generally, the rates of microsomal denitrosation of dialkylnitrosamines occur at~10-20% of the rates of dealkylation, samples that were also examined with inhibitory mAbs showed that depropylation was largely inhibited,~60-90%, by the 2E1 suggesting a close association between the two pathways (6,14,15, and results herein). Of the three purified P450s mAb at 0.25 mM NDPA. K m values between 51 and 86 µM reported for denitrosation in the three microsomal samples examined here, all catalyzed denitrosation of NDPA at a rate of 10-20% that of dealkylation (Table III ). Purified 2B1 was tested are similar to those for denitrosation and depropylation by purified 2E1. This concurs with the observation of a also previously shown to denitrosate nitrosomethylamylamine at~20% of the rate of dealkylation (15) . These findings significant inhibition of depropylation by DDC in these three samples, with one sample also exhibiting almost complete conclusively demonstrate that individual P450s catalyze both reactions and suggest that this may be common for many inhibition by the 2E1 mAb. The ability of human 2E1 to metabolize NDPA to a toxic species, presumably through the dialkylnitrosamines. Mechanistically, studies with deuteriumlabeled NDMA have suggested that P450 oxidizes the nitros-α-hydroxylation pathway, at micromolar concentrations was confirmed in THLE 2E1 cell cultures.
amine to an initial α-nitrosamino radical intermediate which undergoes oxygen rebound to the α-hydroxy compound or P450s 2C18 and/or 2C19 may also partly contribute to the metabolism of NDPA at 0.25 mM in some individuals, as the fragments to nitric oxide and the imine (6). Non-enzymatic generation of the α-nitrosamino radical from NDMA by the 2C mAb inhibited depropylation in sample 136 (~25%). About 25% of the depropylation in sample 39 could not be accounted Fenton reagent also supports this pathway (11) . The same K m values for denitrosation and depropylation of NDPA by each for based on inhibition by the mAbs or the chemical inhibitors. This indicates that unidentified P450s may also contribute to P450 examined (Table III) are consistent with this oxidative mechanism. A P450-mediated reductive denitrosation mechandepropylation at the substrate concentrations tested, although it is possible that inhibition by the mAbs or chemical inhibitors ism, as mentioned above, for NDPA cannot be ruled out, although disparate pathways of oxidative depropylation and is incomplete. P450s 1A1 and 1A2 were not investigated because no correlation between NDPA depropylation and these one electron reductive denitrosation are much less likely to exhibit equivalent K m values. specific activities was seen in the study by Bellec et al. (19) . Also, previous results suggested that rat 1A1 and 1A2 do not NDPA can also be metabolized to a species capable of methylating as well as propylating nucleic acids in rat livers participate in NDPA depropylation (16).
Bellec et al. (19) found 2E1 and 3A4 to be the major in vivo (53). In addition, P450s can oxidize this compound at the β and ω positions, possibly leading to chain shortened isoforms involved in NDPA depropylation in human liver microsomes at substrate concentrations estimated to be saturatderivatives (16,54). The extent of these and other biotransformations in human tissues and the effect they may have on ing. Our results agree with and extend theirs, identifying the 19. Bellec,G., Dreano,Y., Lozach,P., Menez,J.F. and Berthou,F. (1996) tumor initiation is not known. The enzymes involved in the 
